RYOAX Holdings — Biotechnology Fund
All 75 reported holdings of Biotechnology Fund (RYOAX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| AbbVie Inc. | 7.39% | $9.99M |
| Amgen Inc. | 5.23% | $7.07M |
| Gilead Sciences Inc. | 4.96% | $6.70M |
| Vertex Pharmaceuticals Incorporated | 4.01% | $5.41M |
| Regeneron Pharmaceuticals, Inc. | 3.56% | $4.81M |
| Alnylam Pharmaceuticals Inc. | 2.60% | $3.52M |
| Insmed Inc | 2.45% | $3.32M |
| Beone Medicines Ltd. | 2.29% | $3.09M |
| Natera, Inc. | 2.09% | $2.83M |
| United Therapeutics Corporation | 2.07% | $2.79M |
| Biogen Inc | 2.01% | $2.71M |
| Royalty Pharma PLC | 1.98% | $2.67M |
| Illumina Inc | 1.74% | $2.35M |
| Revolution Medicines Inc | 1.69% | $2.28M |
| Moderna Inc | 1.65% | $2.23M |
| AstraZeneca PLC | 1.60% | $2.16M |
| Argenx SE | 1.60% | $2.16M |
| Incyte Corporation. | 1.56% | $2.10M |
| Viatris Inc | 1.50% | $2.03M |
| Bridgebio Pharma Inc | 1.47% | $1.99M |
| Alkermes PLC | 1.47% | $1.98M |
| Jazz Pharmaceuticals PLC | 1.46% | $1.98M |
| Neurocrine Biosciences Inc | 1.42% | $1.91M |
| Guardant Health Inc | 1.41% | $1.90M |
| Roivant Sciences Ltd | 1.40% | $1.89M |
| Ionis Pharmaceuticals, Inc. | 1.38% | $1.87M |
| Exelixis, Inc. | 1.29% | $1.74M |
| Medpace Holdings Inc. | 1.26% | $1.70M |
| Biomarin Pharmaceutical Inc. | 1.24% | $1.68M |
| Apellis Pharmaceuticals Inc | 1.22% | $1.65M |
| Arrowhead Pharmaceuticals Inc | 1.22% | $1.65M |
| Cytokinetics Inc | 1.18% | $1.59M |
| Vaxcyte Inc | 1.14% | $1.53M |
| CRISPR Therapeutics AG | 1.13% | $1.52M |
| Halozyme Therapeutics Inc | 1.09% | $1.47M |
| BioNTech SE | 1.06% | $1.44M |
| Axsome Therapeutics Inc. | 1.02% | $1.38M |
| Ascendis Pharma A/S | 1.01% | $1.37M |
| Cogent Biosciences, Inc. | 0.99% | $1.34M |
| Arcellx Inc | 0.99% | $1.34M |
| TG Therapeutics Inc | 0.96% | $1.30M |
| PTC Therapeutics, Inc. | 0.96% | $1.29M |
| Scholar Rock Holding Corp. | 0.94% | $1.27M |
| Madrigal Pharmaceuticals Inc | 0.90% | $1.22M |
| Mirum Pharmaceuticals Inc. | 0.89% | $1.21M |
| Protagonist Therapeutics Inc | 0.87% | $1.18M |
| Amicus Therapeutics Inc. | 0.82% | $1.10M |
| Rhythm Pharmaceuticals Inc | 0.78% | $1.06M |
| Apogee Therapeutics, Inc. | 0.75% | $1.02M |
| Kymera Therapeutics Inc | 0.72% | $970.99K |
| Twist Bioscience Corporation | 0.71% | $952.97K |
| Viking Therapeutics Inc. | 0.71% | $952.71K |
| Summit Therapeutics, Inc. | 0.69% | $933.08K |
| Nuvalent Inc | 0.69% | $927.48K |
| Acadia Pharmaceuticals Inc | 0.67% | $905.38K |
| Travere Therapeutics Inc | 0.67% | $898.76K |
| Sarepta Therapeutics Inc | 0.65% | $875.32K |
| Celcuity Inc. | 0.65% | $874.08K |
| Arcutis Biotherapeutics, Inc. | 0.64% | $869.91K |
| Veracyte Inc | 0.64% | $859.52K |
| Liquidia Corp. | 0.62% | $835.79K |
| Beam Therapeutics, Inc. | 0.56% | $760.08K |
| Ultragenyx Pharmaceuticals Inc | 0.53% | $713.16K |
| Praxis Precision Medicines Inc | 0.50% | $674.02K |
| GRAIL Inc | 0.49% | $663.05K |
| Soleno Therapeutics Inc | 0.49% | $658.18K |
| Recursion Pharmaceuticals Inc | 0.47% | $641.42K |
| Krystal Biotech Inc | 0.47% | $639.08K |
| Legend Biotech Corp. | 0.47% | $634.13K |
| Intellia Therapeutics Inc | 0.47% | $634.12K |
| Adma Biologics Inc | 0.44% | $591.37K |
| J.p. Morgan Securities LLC | 0.23% | $311.36K |
| Merrill Lynch, Pierce, Fenner & Smith Incorporated | 0.21% | $282.95K |
| Akero Therapeutics Inc | 0.00% | $2 |
| Sanofi SA - Cvr | 0.00% | $1 |
RYOAX overview: performance, fees, allocation and SEC filings